Press releases | Finanzwire

Basculer en Français

10936	Companies
238805	Keywords
167666	Articles
128365	Press releases

Home
Press releases

PRESS RELEASE

published on 12/17/2025 at 11:05, 8 months 18 days ago

An ambitious project to protect consumer health and promote the excellence of extra virgin olive oil FRANCE OLIVE PRODUCTION - UNAPROL
Italian consortium UNAPROL and French association FRANCE OLIVE PRODUCTION collaborate on project to ensure quality and safety of olive oil. Initiative supported by EU regulations

EU Regulations Quality Control Olive Oil Unaprol France Olive Production
PRESS RELEASE

published on 12/17/2025 at 11:05, 8 months 18 days ago

Dstny Celebrates Record-Breaking Year with 10+ International Awards for Cloud Communications Excellence
Dstny celebrates a record-breaking year with 10+ international awards for cloud communications excellence, including Platinum, Gold, and Silver honours across various categories

Technology International Awards EU Cloud Communications Dstny
PRESS RELEASE

published on 12/17/2025 at 11:00, 8 months 18 days ago

Healthcare specialist SHS Capital invests in a leading German Endoscopy Group
SHS Capital invests in leading German Endoscopy Group through SHS VI fund, aiming to strengthen growth and innovation in healthcare sector

Innovation Healthcare Investment SHS Capital Endoscopy Group
PRESS RELEASE

published on 12/17/2025 at 10:57, 8 months 18 days ago

Inside Information / Other news releases
Valerio Therapeutics appoints Prof. Eric Vivier as Observer to Board of Directors. Prof. Vivier, a renowned immunologist, will bring over 30 years of experience to drive innovative tumor treatment approaches

Board Of Directors Valerio Therapeutics Professor Eric Vivier Immunologist Tumor Treatment
PRESS RELEASE

published on 12/17/2025 at 10:40, 8 months 18 days ago

Brödernas publishes quarterly report for Jan-Sep 2025
Brödernas Group AB publishes Q3 2025 financial report with SEK 287m net sales and net leverage ratio exceeding 6.00x, leading to default event under bond terms

Financial Report Net Sales Leverage Ratio Brödernas Group AB Q3 Report
PRESS RELEASE

published on 12/17/2025 at 10:05, 8 months 18 days ago

UTI Investments Partners with FTSE Russell to Transition its Sovereign Bond ETF Benchmark
UTI Investments partners with FTSE Russell to transition its Sovereign Bond ETF benchmark from Nifty India Government FAR Index to FTSE Indian Government Bond FAR Index, reflecting global interest in India's fixed income markets

FTSE Russell UTI Investments Sovereign Bond ETF FTSE Indian Government Bond FAR Index India Government Bonds
PRESS RELEASE

published on 12/17/2025 at 09:30, 8 months 18 days ago

Topadur Appoints Matthias Schäfer as Chief Executive Officer to Lead Next Phase of Company Growth
Topadur Pharma AG appoints Matthias Schäfer as Chief Executive Officer to lead company growth into next phase of clinical development and expansion. Dr. Reto Naef transitions to Senior Scientific Advisor

Clinical Development Chief Executive Officer Topadur Pharma AG Matthias Schäfer Scientific Advisor
PRESS RELEASE

published on 12/17/2025 at 09:30, 8 months 18 days ago

Designated Person Notification
Aperam announces Designated Person Notification regarding share transactions as per Market Abuse Regulations. Aperam is a global stainless steel player committed to the circular economy

Share Transactions Market Abuse Regulations Aperam Circular Economy Designated Person Notification
PRESS RELEASE

published on 12/17/2025 at 09:21, 8 months 18 days ago

Heidelberg Pharma: Letter from the CEO
Heidelberg Pharma CEO addresses delays in milestone payment, emphasizing continued development of TLX250-CDx and promising phase I study results for pamlectabart tismanitin (HDP-101). Financial challenges are being addressed proactively

CEO Heidelberg Pharma Milestone Payment TLX250-CDx Pamlectabart Tismanitin
PRESS RELEASE

published on 12/17/2025 at 09:05, 8 months 18 days ago

Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
Norgine enhances hepatology and specialty portfolio by in-licensing Vir Biotechnology's chronic hepatitis delta treatment for Europe, Australia, and New Zealand

Exclusive Licensing Agreement Specialty Pharmaceuticals Norgine Vir Biotechnology Chronic Hepatitis Delta Treatment

Accesswire

Published on 09/04/2026 at 23:30, 1 hour 22 minutes ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 1 hour 52 minutes ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 hours 22 minutes ago

Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 10 hours 22 minutes ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/04/2026 at 14:00, 10 hours 52 minutes ago

Horizon Aircraft Appoints Tom Hearne to Board of Directors and Names Him Audit Committee Chair

View all ACCESSWIRE

EQS Group

Published on 09/04/2026 at 22:10, 2 hours 41 minutes ago

Quantinuum to Participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference
Published on 09/04/2026 at 19:20, 5 hours 31 minutes ago

Dahua Technology Showcases Integrated Smart Living and Innovations at IFA Berlin 2026
Published on 09/04/2026 at 18:55, 5 hours 57 minutes ago

Holding(s) in Company
Published on 09/04/2026 at 18:50, 6 hours 1 minute ago

A&S Resources secures railway funding of USD$6 Billion to unlock $2.5 trillion iron ore asset
Published on 09/04/2026 at 18:05, 6 hours 46 minutes ago

Grundig Unveils New Product Lineup at IFA 2026, Marking a New Phase in Strategic Partnership

Les Echos

Published on 09/04/2026 at 18:57, 5 hours 54 minutes ago

Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 7 hours 7 minutes ago

Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 17:45, 7 hours 7 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 09/04/2026 at 16:00, 8 hours 52 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 8 hours 52 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026

View all LES ECHOS COMFI WIRE